Xenazine

Xenazine is a brand name of tetrabenazine, approved by the FDA in the following formulation(s):

XENAZINE (tetrabenazine - tablet; oral)

• 
  Manufacturer: VALEANT INTL
  
  Approval date: August 15, 2008
  
  Strength(s): 12.5MG, 25MG ^[RLD]

Has a generic version of Xenazine been approved?

No. There is currently no therapeutically equivalent version of Xenazine available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xenazine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Xenazine.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 15, 2013 - NEW CHEMICAL ENTITY
  
  
  • August 15, 2015 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Xenazine Consumer Information (Drugs.com)
• Xenazine Consumer Information (Wolters Kluwer)
• Xenazine Consumer Information (Cerner Multum)
• Xenazine Advanced Consumer Information (Micromedex)
• Xenazine AHFS DI Monographs (ASHP)
• Tetrabenazine Consumer Information (Wolters Kluwer)
• Tetrabenazine Consumer Information (Cerner Multum)
• Tetrabenazine Advanced Consumer Information (Micromedex)
• Tetrabenazine AHFS DI Monographs (ASHP)